LifeMD (LFMD) Share-based Compensation (2012 - 2025)

LifeMD has reported Share-based Compensation for 14 years, with the latest figure at -$7.3 million in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation fell 335.31% year-over-year to -$7.3 million; the trailing twelve-month figure through Dec 2025 stood at -$2.7 million (down 123.62% YoY), and the FY2025 full-year result was $535000.0, down 95.63% from the prior year.
• Share-based Compensation for Q4 2025 stood at -$7.3 million, down from $2.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $4.5 million in Q1 2022, with the low at -$7.3 million in Q4 2025.
• Historically, Share-based Compensation has averaged $2.3 million across 5 years, with a median of $2.9 million in 2023.
• Annual changes were most pronounced in 2021 — Share-based Compensation surged 2325.21% — and 2025, when it plunged 335.31%.
• LifeMD's Share-based Compensation stood at $4.1 million in 2021, then tumbled by 55.12% to $1.8 million in 2022, then jumped by 98.71% to $3.6 million in 2023, then declined by 14.83% to $3.1 million in 2024, then sank by 335.31% to -$7.3 million in 2025.
• The last three Share-based Compensation figures came in at -$7.3 million (Q4 2025), $2.1 million (Q2 2025), and $2.5 million (Q1 2025), per Business Quant data.